The Swiss pharmaceutics group Novartis produced the first anti-swine flu vaccine batch. The vaccine will be clinically tested. The product might be finalised until this autumn, the companyinforms.
The vaccine was produced by using cell cultures, a quicker way than using the classic egg procedure, according to Novartis report. This procedure made possible the quick creation of the fist vaccine batch.
WHO declared world swine flu pandemic on Thursday - alert level 6. This is the first global pandemic of the century.
